These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 170826

  • 21. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ, Buck RH, Joubert SM.
    S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933
    [Abstract] [Full Text] [Related]

  • 22. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug 01; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 23. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct 01; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 24. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH, Cannon W, Benedet JL, Boyes DA.
    Am J Obstet Gynecol; 1977 Apr 01; 127(7):711-2. PubMed ID: 557901
    [Abstract] [Full Text] [Related]

  • 25. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN, Bohn H, Csaba IF, Szabó DG, Karg NJ, Göcze P.
    Arch Gynecol; 1981 Apr 01; 231(1):33-9. PubMed ID: 6174083
    [Abstract] [Full Text] [Related]

  • 26. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U, Papadogiannakis N, Lindell G, Marions L.
    J Reprod Med; 2011 Apr 01; 56(11-12):511-4. PubMed ID: 22195336
    [Abstract] [Full Text] [Related]

  • 27. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN, Salem HT, Al-Ani AT, Chard T, Huang SC, Ouyang PC, Wei PY, Seppälä M.
    Am J Obstet Gynecol; 1981 Mar 15; 139(6):702-4. PubMed ID: 6971058
    [Abstract] [Full Text] [Related]

  • 28. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr 15; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 29. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL.
    J Clin Endocrinol Metab; 1988 Mar 15; 66(3):557-64. PubMed ID: 2450890
    [Abstract] [Full Text] [Related]

  • 30. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK, Daunter B.
    Aust N Z J Obstet Gynaecol; 1980 Feb 15; 20(1):35-42. PubMed ID: 6248013
    [Abstract] [Full Text] [Related]

  • 31. [Determination of low unit hCG Higonavis: application to the management of chorionic tumor].
    Tojo S, Kanazawa S, Maruo T, Mikami K, Sakagami A.
    Horumon To Rinsho; 1973 Nov 15; 21(11):1179-86. PubMed ID: 4360619
    [No Abstract] [Full Text] [Related]

  • 32. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease.
    Osathanondh R, Berkowitz RS, de Cholnoky C, Smith BS, Goldstein DP, Tyson JE.
    J Reprod Med; 1986 Mar 15; 31(3):179-83. PubMed ID: 3009803
    [Abstract] [Full Text] [Related]

  • 33. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul 15; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 34. Gonadotropin-releasing hormone-induced elevation of serum hCG in choriocarcinoma: a case report.
    Furuhashi M, Miyabe Y, Katsumata Y, Oda H, Imai N.
    Endocr J; 1998 Aug 15; 45(4):585-90. PubMed ID: 9881911
    [Abstract] [Full Text] [Related]

  • 35. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar 15; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 36. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug 15; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 37. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
    Hirashima N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May 15; 32(5):592-600. PubMed ID: 6263999
    [Abstract] [Full Text] [Related]

  • 38. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN, Salem HT, Chard T, Huang SC, Ouyang PC.
    Br J Obstet Gynaecol; 1982 Jan 15; 89(1):69-72. PubMed ID: 6277363
    [Abstract] [Full Text] [Related]

  • 39. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA, Hussa RO.
    J Reprod Med; 1984 Nov 15; 29(11):802-12. PubMed ID: 6097684
    [Abstract] [Full Text] [Related]

  • 40. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR, Hatch KD, Younger JB.
    Ala J Med Sci; 1983 Oct 15; 20(4):391-4. PubMed ID: 6316799
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.